Health Economics and Outcomes Research (HEOR)

EVIDENCE, VALUE AND ACCESS

Our HEOR analysts and economic modelers have proven track record in conducting systematic reviews/meta-analysis
and creating user-friendly economic models.

Health Economics and Outcomes Research (HEOR)

Comparative Effectiveness Research (CER)

  • Systematic Literature Reviews (SLRs)
  • Meta-Analysis
  • Indirect Treatment Comparison
  • Mixed Treatment Comparison
  • Network Meta-Analysis (NMA)
  • Model Based Meta-Analysis (MBMA)

Economic Modeling and Evaluation

  • Cost Benefit Analysis (CBA)
  • Cost Effective Analysis (CEA)
  • Cost Utility Analysis (CUA)
  • Cost Minimization Analysis (CMA)
  • Cost of Illness Analysis (COI)
  • Cost Consequence Analysis (CCA)
  • Budget Impact Models
  • Disease Burden Models
  • Markov Models
  • Bayesian Models
  • Country Specific Modeling Adaptations

Health Technology Assessment (HTA)

  • National Institute for Health and Clinical Excellence (NICE), including
  • Scottish Medicines Consortium (SMC)
  • Canadian Agency for Drugs and Technologies in Health (CADTH)
  • Pharmaceutical Benefits Advisory Committee (PBAC)
  • Institute for Quality and Efficiency in Health Care (IQWiG)

Patient Reported Outcomes (PROs)

  • Trial Based Services
  • Analysis and Validation
  • Communication